Berson Andrew J, Smith J Michael, Woods Scott E, Hasselfeld Kimberly A, Hiratzka Loren F
Department of Surgery, Good Samaritan Hospital, Cincinnati, OH 45220, USA.
J Am Coll Surg. 2004 Jul;199(1):102-8. doi: 10.1016/j.jamcollsurg.2004.03.014.
This study assessed hospitalization outcome differences for patients undergoing off-pump coronary artery bypass (OPCAB) grafting compared with patients having coronary artery bypass grafting with cardiopulmonary bypass.
We conducted a nested case-control study from an 8-year, hospitalization cohort (n = 7,905) in which the data were collected prospectively. Inclusion criteria included a coronary artery bypass graft only and age greater than 18 years. Cases were patients undergoing OPCAB (n = 360) and controls were patients undergoing coronary artery bypass grafting with cardiopulmonary bypass (n = 1,080). Cases were matched to controls 1:3 on five variables: age (+/- 3 years), gender, diabetes, New York Heart Association Functional Classification, and surgical year (+/- 3 years). The 13 outcomes of interest were mortality, length of hospitalization, ICU length of stay, return to ICU, ventilator time, intraoperative complications, pulmonary complications, neurologic complications, renal complications, gastrointestinal complications, sternal wound infections, highest postoperative creatine kinase level, and units of blood products given during the procedure. Using logistic regression we controlled for eight confounding variables.
Patients undergoing OPCAB had a significantly shorter length of hospitalization (relative risk [RR] = 0.95; 95% CI, 0.91-0.99%), fewer pulmonary complications (RR = 0.45; 95% CI, 0.22-0.88%), fewer intraoperative complications (RR = 0.04; 95% CI, 0.0048-0.31%) fewer blood product units given (RR = 0.31; 95% CI, 0.14-0.42%) and lower postoperative creatine kinase (RR = 0.99; 95% CI, 0.98-0.99%). There were no considerable differences for the remaining nine outcomes, including mortality and neurologic complications.
Patients undergoing OPCAB had a considerably shorter length of hospitalization, had fewer pulmonary and intraoperative complications, and received a lower volume of blood products.
本研究评估了非体外循环冠状动脉搭桥术(OPCAB)患者与体外循环冠状动脉搭桥术患者的住院结局差异。
我们对一个8年的住院队列(n = 7905)进行了巢式病例对照研究,数据为前瞻性收集。纳入标准包括仅行冠状动脉搭桥术且年龄大于18岁。病例为接受OPCAB的患者(n = 360),对照为接受体外循环冠状动脉搭桥术的患者(n = 1080)。病例与对照按1:3在五个变量上进行匹配:年龄(±3岁)、性别、糖尿病、纽约心脏协会功能分级和手术年份(±3年)。感兴趣的13项结局为死亡率、住院时间、重症监护病房(ICU)住院时间、返回ICU、呼吸机使用时间、术中并发症、肺部并发症、神经并发症、肾脏并发症、胃肠道并发症、胸骨伤口感染、术后最高肌酸激酶水平以及手术过程中输注的血制品单位数。我们使用逻辑回归控制了8个混杂变量。
接受OPCAB的患者住院时间显著缩短(相对风险[RR]=0.95;95%可信区间[CI],0.91 - 0.99%),肺部并发症较少(RR = 0.45;95%CI,0.22 - 0.88%),术中并发症较少(RR = 0.04;95%CI,0.0048 - 0.31%),输注的血制品单位数较少(RR = 0.31;95%CI,0.14 - 0.42%),术后肌酸激酶水平较低(RR = 0.99;95%CI,0.98 - 0.99%)。其余9项结局,包括死亡率和神经并发症,没有显著差异。
接受OPCAB的患者住院时间明显缩短,肺部和术中并发症较少,且输注的血制品量较低。